Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retinal Vascular Occlusion after COVID-19 Vaccination: More Coincidence than Causal Relationship? Data from a Retrospective Multicentre Study.
Feltgen N, Ach T, Ziemssen F, Quante CS, Gross O, Abdin AD, Aisenbrey S, Bartram MC, Blum M, Brockmann C, Dithmar S, Friedrichs W, Guthoff R, Hattenbach LO, Herrlinger KR, Kaskel-Paul S, Khoramnia R, Klaas JE, Krohne TU, Lommatzsch A, Lueken S, Maier M, Nassri L, Nguyen-Dang TA, Radeck V, Rau S, Roider J, Sandner D, Schmalenberger L, Schmidtmann I, Schubert F, Siegel H, Spitzer MS, Stahl A, Stingl JV, Treumer F, Viestenz A, Wachtlin J, Wolf A, Zimmermann J, Schargus M, Schuster AK. Feltgen N, et al. Among authors: wolf a. J Clin Med. 2022 Aug 30;11(17):5101. doi: 10.3390/jcm11175101. J Clin Med. 2022. PMID: 36079030 Free PMC article.
Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination.
Callizo J, Feltgen N, Pantenburg S, Wolf A, Neubauer AS, Jurklies B, Wachter R, Schmoor C, Schumacher M, Junker B, Pielen A; European Assessment Group for Lysis in the Eye. Callizo J, et al. Among authors: wolf a. Ophthalmology. 2015 Sep;122(9):1881-8. doi: 10.1016/j.ophtha.2015.05.044. Epub 2015 Jul 21. Ophthalmology. 2015. PMID: 26231133 Clinical Trial.
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO; COMRADE-C Study Group. Hoerauf H, et al. Among authors: wolf a. Am J Ophthalmol. 2016 Sep;169:258-267. doi: 10.1016/j.ajo.2016.04.020. Epub 2016 May 7. Am J Ophthalmol. 2016. PMID: 27163237 Clinical Trial.
Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study.
Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A, Berk H, Eter N, Lang GE, Pielen A, Schmitz-Valckenberg S, Quiering C, Rose U, Hoerauf H; COMRADE Study Group. Feltgen N, et al. Among authors: wolf a. Acta Ophthalmol. 2018 Dec;96(8):e933-e941. doi: 10.1111/aos.13770. Epub 2018 May 31. Acta Ophthalmol. 2018. PMID: 29855153 Free article. Clinical Trial.
Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials.
Pielen A, Feltgen N, Hattenbach LO, Hoerauf H, Bertelmann T, Quiering C, Vögeler J, Priglinger S, Lang GE, Schmitz-Valckenberg S, Wolf A, Rehak M. Pielen A, et al. Among authors: wolf a. Curr Eye Res. 2020 May;45(5):604-614. doi: 10.1080/02713683.2019.1679839. Epub 2019 Oct 31. Curr Eye Res. 2020. PMID: 31665935 Clinical Trial.
3,251 results